AKERO THERAPEUTICS INC

CUSIP: 00973Y108 Class: Common Stock

MetLife Investment Management, LLC's Holding History (CIK: 0001529735)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 41,664 Value ($000) $1,978 Avg Close Range
Q2 2025
Shares 41,664 Value ($000) $2,223 Avg Close Range
Q1 2025
Shares 43,498 Value ($000) $1,761 Avg Close Range
Q4 2024
Shares 41,565 Value ($000) $1,156 Avg Close Range
Q3 2024
Shares 39,243 Value ($000) $1,126 Avg Close Range
Q2 2024
Shares 39,243 Value ($000) $921 Avg Close Range
Q1 2024
Shares 32,240 Value ($000) $814 Avg Close Range
Q4 2023
Shares 26,995 Value ($000) $630 Avg Close Range
Q3 2023
Shares 26,995 Value ($000) $1,365 Avg Close Range
Q2 2023
Shares 23,684 Value ($000) $1,106 Avg Close Range
Q1 2023
Shares 18,279 Value ($000) $699 Avg Close Range
Q4 2022
Shares 18,279 Value ($000) $1,002 Avg Close Range
Q3 2022
Shares 15,580 Value ($000) $530 Avg Close Range
Q2 2022
Shares 15,580 Value ($000) $147 Avg Close Range
Q1 2022
Shares 15,580 Value ($000) $221 Avg Close Range
Q4 2021
Shares 9,830 Value ($000) $208 Avg Close Range
Q3 2021
Shares 9,830 Value ($000) $220 Avg Close Range
Q2 2021
Shares 9,830 Value ($000) $244 Avg Close Range
Q1 2021
Shares 5,589 Value ($000) $162 Avg Close Range
Q4 2020
Shares 5,589 Value ($000) $144 Avg Close Range
Q3 2020
Shares 5,589 Value ($000) $172 Avg Close Range
Q2 2020
Shares 5,589 Value ($000) $139 Avg Close Range